Serum corin is associated with the risk of chronic heart failure

Zongliang Yu1, Xiang Lu2, Weiting Xu3

  • 1Department of Cardiology, The First People's Hospital of Kunshan Affiliated to Jiangsu University, Kunshan, China.

Oncotarget
|December 17, 2017
PubMed

Insights

Serum corin levels are lower in patients with chronic heart failure (CHF). Lower corin levels are associated with increased risk and severity of both ischemic and non-ischemic heart failure.

Area of Science:

  • Cardiology
  • Biochemistry
  • Protease Function

Background:

  • Corin is a critical protease regulating blood pressure and cardiac function.
  • Understanding factors associated with chronic heart failure (CHF) risk is crucial for cardiovascular health.
  • Previous research highlights corin's role in cardiovascular homeostasis.

Purpose of the Study:

  • To investigate the association between serum corin levels and the risk of chronic heart failure (CHF).
  • To determine if serum corin levels correlate with the incidence of ischemic and non-ischemic heart failure.
  • To explore the relationship between serum corin levels and CHF severity.

Main Methods:

  • A case-control study involving 484 CHF patients and 484 healthy controls.
  • Logistic regression analysis was employed to assess the relationship between serum corin and CHF.
  • Multivariate analysis was used to adjust for potential confounding factors.

Main Results:

  • CHF patients exhibited significantly lower serum corin levels compared to controls.
  • Lower serum corin levels were inversely correlated with the risk of both ischemic and non-ischemic heart failure.
  • Decreased serum corin levels were associated with increased CHF severity.

Conclusions:

  • Serum corin levels are reduced in patients with chronic heart failure.
  • Reduced serum corin is a potential biomarker for increased risk and severity of heart failure.
  • Corin may play a protective role in the pathogenesis of heart failure.

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
648
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
430
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
737
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
559